Frankfurt - Delayed Quote EUR
Amgen Inc. (AMG.F)
245.00
+1.00
+(0.41%)
At close: April 24 at 2:32:46 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 22 | 20 | 29 | 26 |
| Avg. Estimate | 8.04B | 8.84B | 35.1B | 35.89B |
| Low Estimate | 7.71B | 8.54B | 33.79B | 34.48B |
| High Estimate | 8.46B | 9.14B | 35.94B | 37.99B |
| Year Ago Sales | 7.45B | 8.39B | 33.42B | 35.1B |
| Sales Growth (year/est) | 7.97% | 5.34% | 5.00% | 2.27% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| AMG.F | -- | -- | -- | -- |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Upgrades & Downgrades
| Initiated | Cantor Fitzgerald: Overweight | 4/22/2025 |
| Maintains | UBS: Neutral to Neutral | 4/14/2025 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 4/9/2025 |
| Maintains | B of A Securities: Underperform to Underperform | 3/5/2025 |
| Maintains | Piper Sandler: Overweight to Overweight | 2/10/2025 |
| Maintains | B of A Securities: Underperform to Underperform | 2/6/2025 |
Related Tickers
IDP.HM Biogen Inc
105.20
+0.91%
0QCV.IL AbbVie Inc.
178.90
+0.85%
GIS.F Gilead Sciences, Inc.
93.51
+0.73%
GLAXF GSK plc
18.46
+6.58%
CUP.F Chugai Pharmaceutical Co., Ltd.
50.40
-0.79%
REC.MI Recordati Industria Chimica e Farmaceutica S.p.A.
49.22
+0.49%
LLY.F Eli Lilly and Company
757.00
+3.88%
NOV.DE Novo Nordisk A/S
54.96
+1.33%
SNY Sanofi
53.54
+0.98%
GSK GSK plc
37.50
+1.27%